{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T10:52:22Z","timestamp":1775991142694,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/bmt.2015.237","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T14:41:44Z","timestamp":1445870504000},"page":"418-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties"],"prefix":"10.1038","volume":"51","author":[{"given":"O","family":"Penack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Tridello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Hoek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Craddock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Veelken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-3245","authenticated-orcid":false,"given":"P","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Thiebaut-Bertrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Lioure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Michallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Iacobelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,26]]},"reference":[{"key":"BFbmt2015237_CR1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbmt.2004.02.006","volume":"10","author":"T Fukuda","year":"2004","unstructured":"Fukuda T, Boeckh M, Guthrie KA, Mattson DK, Owens S, Wald A et al. Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center. Biol Blood Marrow Transplant 2004; 10: 494\u2013503.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015237_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/339202","volume":"34","author":"KA Marr","year":"2002","unstructured":"Marr KA, Carter RA, Crippa F, Wald A, Corey L . Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909\u2013917.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2015237_CR3","first-page":"297","volume":"82","author":"R Martino","year":"1997","unstructured":"Martino R, Lopez R, Sureda A, Brunet S, Domingo-Albos A . Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature. Haematologica 1997; 82: 297\u2013304.","journal-title":"Haematologica"},{"key":"BFbmt2015237_CR4","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1086\/520274","volume":"26","author":"F Offner","year":"1998","unstructured":"Offner F, Cordonnier C, Ljungman P, Prentice HG, Engelhard D, De Bacquer D et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998; 26: 1098\u20131103.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2015237_CR5","first-page":"265","volume":"13","author":"R Martino","year":"1994","unstructured":"Martino R, Nomdedeu J, Altes A, Sureda A, Brunet S, Martinez C et al. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases. Bone Marrow Transplant 1994; 13: 265\u2013269.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015237_CR6","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.3324\/haematol.2009.020073","volume":"95","author":"C Cordonnier","year":"2010","unstructured":"Cordonnier C, Rovira M, Maertens J, Olavarria E, Faucher C, Bilger K et al. Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study. Haematologica 2010; 95: 1762\u20131768.","journal-title":"Haematologica"},{"key":"BFbmt2015237_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","volume":"20","author":"C Girmenia","year":"2014","unstructured":"Girmenia C, Raiola AM, Piciocchi A, Algarotti A, Stanzani M, Cudillo L et al. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant 2014; 20: 872\u2013880.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015237_CR8","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1182\/blood-2006-03-008706","volume":"108","author":"R Martino","year":"2006","unstructured":"Martino R, Parody R, Fukuda T, Maertens J, Theunissen K, Ho A et al. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2006; 108: 2928\u20132936.","journal-title":"Blood"},{"key":"BFbmt2015237_CR9","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1080\/10428190701534390","volume":"48","author":"BT Hill","year":"2007","unstructured":"Hill BT, Kondapalli L, Artz A, Smith S, Rich E, Godley L et al. Successful allogeneic transplantation of patients with suspected prior invasive mold infection. Leukemia & lymphoma 2007; 48: 1799\u20131805.","journal-title":"Leukemia & lymphoma"},{"key":"BFbmt2015237_CR10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/jac\/dkm521","volume":"61","author":"K Allinson","year":"2008","unstructured":"Allinson K, Kolve H, Gumbinger HG, Vormoor HJ, Ehlert K, Groll AH . Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients. J Antimicrob Chemother 2008; 61: 734\u2013742.","journal-title":"J Antimicrob Chemother"},{"key":"BFbmt2015237_CR11","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.bmt.1704469","volume":"33","author":"C Cordonnier","year":"2004","unstructured":"Cordonnier C, Maury S, Pautas C, Bastie JN, Chehata S, Castaigne S et al. Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients. Bone Marrow Transplant 2004; 33: 943\u2013948.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2015237_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1164\/ajrccm.158.3.9801056","volume":"158","author":"F Reichenberger","year":"1998","unstructured":"Reichenberger F, Habicht J, Kaim A, Dalquen P, Bernet F, Schlapfer R et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med 1998; 158: 885\u2013890.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFbmt2015237_CR13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/annonc\/mdi238","volume":"16","author":"WH Kruger","year":"2005","unstructured":"Kruger WH, Bohlius J, Cornely OA, Einsele H, Hebart H, Massenkeil G et al. Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncology. Ann Oncol 2005; 16: 1381\u20131390.","journal-title":"Ann Oncol"},{"key":"BFbmt2015237_CR14","doi-asserted-by":"crossref","unstructured":"Sullivan KM, Dykewicz CA, Longworth DL, Boeckh M, Baden LR, Rubin RH et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program 2001, 392\u2013421.","DOI":"10.1182\/asheducation-2001.1.392"},{"key":"BFbmt2015237_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143\u20131238.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2015237_CR16","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","volume":"31","author":"E Azoulay","year":"2013","unstructured":"Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium\u2014a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 2013; 31: 2810\u20132818.","journal-title":"J Clin Oncol"},{"key":"BFbmt2015237_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","volume":"40","author":"M Legrand","year":"2012","unstructured":"Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 43\u201349.","journal-title":"Crit Care Med"},{"key":"BFbmt2015237_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/annonc\/mdu192","volume":"26","author":"G Maschmeyer","year":"2015","unstructured":"Maschmeyer G, Carratala J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)dagger. Ann Oncol 2015; 26: 21\u201333.","journal-title":"Ann Oncol"},{"key":"BFbmt2015237_CR19","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","volume":"116","author":"JR Wingard","year":"2010","unstructured":"Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood 2010; 116: 5111\u20135118.","journal-title":"Blood"},{"key":"BFbmt2015237_CR20","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1086\/422312","volume":"39","author":"JA van Burik","year":"2004","unstructured":"van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004; 39: 1407\u20131416.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2015237_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa061098","volume":"356","author":"AJ Ullmann","year":"2007","unstructured":"Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007; 356: 335\u2013347.","journal-title":"N Engl J Med"},{"key":"BFbmt2015237_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaci.2011.12.970","volume":"129","author":"AP Knutsen","year":"2012","unstructured":"Knutsen AP, Bush RK, Demain JG, Denning DW, Dixit A, Fairs A et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012; 129: 280\u2013291; quiz 292-3.","journal-title":"J Allergy Clin Immunol"},{"key":"BFbmt2015237_CR23","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","volume":"118","author":"AH Elmaagacli","year":"2011","unstructured":"Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011; 118: 1402\u20131412.","journal-title":"Blood"},{"key":"BFbmt2015237_CR24","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1182\/blood-2013-05-499830","volume":"122","author":"M Schmidt-Hieber","year":"2013","unstructured":"Schmidt-Hieber M, Labopin M, Beelen D, Volin L, Ehninger G, Finke J et al. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT. Blood 2013; 122: 3359\u20133364.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2015237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015237","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2015237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:10:35Z","timestamp":1648059035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2015237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,26]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFbmt2015237"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2015.237","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,26]]},"assertion":[{"value":"15 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}